Quick Answer
CME GROUP INC. reported Cash and Equivalents of $4.42 billion for fiscal year 2025.
CME GROUP INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.42B | +52.7% |
| 2024 | $2.89B | -0.7% |
| 2023 | $2.91B | +7.1% |
| 2022 | $2.72B | -4.0% |
| 2021 | $2.83B | +73.6% |
| 2020 | $1.63B | +5.3% |
| 2019 | $1.55B | +12.9% |
| 2018 | $1.37B | -27.8% |
| 2017 | $1.90B | +1.9% |
| 2016 | $1.87B | +10.4% |
| 2015 | $1.69B | +23.9% |
| 2014 | $1.37B | -44.7% |
| 2013 | $2.47B | +53.9% |
| 2012 | $1.60B | +54.0% |
| 2011 | $1.04B | +21.9% |
| 2010 | $855.20M | +228.2% |
| 2009 | $260.60M | -12.5% |
| 2008 | $297.90M | -64.8% |
| 2007 | $845.30M | -12.8% |
| 2006 | $969.50M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.45B | +5.4% | +23.5% |
| June 30, 2025 | $1.98B | +10.7% | +41.0% |
| March 31, 2025 | $1.41B | -2.2% | -51.4% |
| December 31, 2024 | $2.89B | -0.7% | +24.6% |
| September 30, 2024 | $2.32B | +1.0% | +29.7% |
| June 30, 2024 | $1.79B | -4.8% | +24.6% |
| March 31, 2024 | $1.44B | -8.2% | -50.7% |
| December 31, 2023 | $2.91B | +7.1% | +26.6% |
- CME GROUP INC. showed an increase of +52.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2025 period, CME GROUP INC.’s cash and equivalents has grown by 355.6% (from $969.50 million to $4.42 billion).
- The most recent figure is from CME GROUP INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: